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Abstract 
Aims: 
A survey was conducted amongst university students to assess their level of 
susceptibility and knowledge of measles, mumps and rubella (MMR) diseases and their 
prevention, and find factors associated to the seropositivity for MMR viruses. 
Subjects, and Methods: 
A cross-sectional study was conducted involving 961 students from the University of 
Cassino (Italy). Enzyme immunoassay method was used to assess seropositivity for 
MMR, while knowledge and previous vaccination information were acquired through a 
self-administered questionnaire. 
Results: 
The prevalence of IgG antibodies was 93.2 % for measles, 91.4 % for mumps and 
81.3% for rubella. The susceptibility for measles was higher in the 21-25 and over 31 
age groups . The seroprevalence profile of mumps was similar to that of measles while 
the level of immunity to rubella was very low in students aged under 20 years (76.7%) 
and 21-25 years(81.2%). Only 111 students declared to be vaccinated against measles, 
46 against mumps and 103 against rubella. Most students demonstrated poor knowledge 
concerning MMR and were not practicing preventive behaviours.  
Conclusions: 
The susceptibility was particularly high for rubella. Concerted efforts are needed to 
educate young adults about the benefits of vaccination and to raise their level of 
consciousness so as to motivate them to request vaccination.  
Keywords 
University students, Italy, immunization, measles, mumps, rubella. 
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Introduction 
In Europe, the incidence rate of measles varies among countries. In some nations it is a 
big Public Health concern whilst in others, it is almost overcome (WHO 2003). Italy has 
been facing an upsurge of measles cases after an incidence rate of 1/100 000 inhabitants 
in 2006. Between  September 2007 and May 2008,  2 079 cases were notified and the 
incidence rate increased to 3.4 cases/100 000 inhabitants. Using national age-specific 
population figures as denominators, adolescents aged 15-19 years had the highest 
incidence rate, namely 15.8/100 000 (EUVAV/NET 2007; Filia et al. 2008).  
Regarding rubella, from January 2005 to May 2008, four Italian Regions (Lazio, 
Campania, Tuscany and Piedmont) reported 27 notifications of suspected congenital 
rubella syndrome (CRS), and in 4 cases, the diagnosis was confirmed by laboratory 
tests. In the same period, ten Regions reported 75 suspected cases of rubella during 
pregnancy (in 30 cases the diagnosis was confirmed by laboratory tests).  The mean age 
of cases was 29 years (range 17-46 years) (Giambi et al. 2008). 
Concerning mumps in Italy, an endemo-epidemic course can be observed with 
outbreaks every 2-4 years and its incidence had remained almost unvaryied until 2001, 
with a range from 25.9 to 125.1 cases per 100 00 inhabitants being noted. Since 2002 
cases of mumps have decreased with an incidence of 4.5  per 100 00 inhabitants in 2004 
(Gabutti et al. 2008). 
In Italy vaccinations for measles, mumps and rubella (MMR) are not mandatory. They 
were introduced separately, during the 1970s for rubella and measles, and in 1982 for 
mumps. No specific target for voluntary vaccinations had been set by central health 
authorities, and no organic policy offering this type of vaccinations existed until 1995 
when the Ministry of Health (no. 13, 6 June 1995) established an active offer of MMR 
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combined vaccination, free of charge, targeting 15 month old children and started 
specific informative and educational programmes (Bonanni et al. 2002).  
The National Health Plan 1998–2000 set a 95% coverage goal for both compulsory and 
recommended vaccinations. The immunisation schedule recommended that the first 
dose of MMR vaccine should be given between age 12 to15 months, and a second dose 
from age 5 to 6 or from age 11 to 12 years of age (Ministerial Decree 1999). Rubella 
vaccination, recommended since 1972 for pre-adolescent girls,  continues to be 
recommended until high levels of coverage in the second year of life are reached 
(Ministry of Health 1999). 
All described programmes have already reduced the MMR incidence  in Italy but 
outbreaks are  still recurrent in non immune subjects. In addition, no region achieved 
the target coverage of 95% with the first dose in 2006 (Filia et al. 2008; Giambi et al. 
2008; Ministry of Health  2006). Furthermore, homogeneous results have not yet been 
achieved in Italy (Bonanni et al. 2007; Ciofi degli Atti et al. 2006; Langiano et al. 2005; 
Langiano et al. 2007)
 
and there are great variations in the coverage value not only 
among the Regions but also among Local Health Units within the same Region. 
Although this situation has led to a slowdown in the circulation of viruses, values 
capable of preventing their spread have not yet been reached (Ministerial Decree 1999). 
This explains the shift in the average age of cases, thus exposing adolescents and young 
adults to a greater susceptibility to infection (Trevisan et al. 2005).  
In the province of Frosinone (Lazio Region – Central Italy), which has 490,000 
inhabitants, MMR vaccination coverage prevalence values were 14.5% in 1995 and 
have risen to 62.9% in 2000. An increase in the percentage of subjects aged 10-14 years 
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for measles cases and 15-19 year-olds for rubella cases  was observed between 1995 and 
2003 (Langiano et al. 2005; Langiano et al. 2007). 
Low prevalence of positive antibodies among subjects aged about 20 years to mumps, 
or measles, or rubella  or to all diseases simultaneously was largely witnessed by Italian 
and international studies (Langiano et al. 2005; Trevisan et al. 2005; Hamilton-West 
2006; Giambi et al. 2007; Donaghy et al 2006; WHO 2005). 
This epidemic trend and the low MMR vaccination coverage rate in this geographic area 
has suggested we pay special attention to infections in young adults’ because of  more 
important implications for population health due to more serious complications for these 
individuals (Gabutti et al. 2008; Hamilton-West 2006; Presidency of the Council of 
Ministers 2003; Banatvala and Brown 2004; Kare 2005; Ouhilal 2000; Langiano et al. 
2009 ).   
On the basis of these considerations, the aims of our study were: 
a) to assess the level of susceptibility for Measles, Mumps and Rubella  in a sample 
of university students in order to evaluate possible windows of susceptibility  
accumulating within this specific sub-population; 
b) to find factors associated to the seropositivity for MMR viruses. 
c) to examine the knowledge of these students regarding MMR diseases and their 
prevention. 
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Subjects and Methods 
Study population 
A cross-sectional study was conducted involving 961 students from the University of 
Cassino, the only campus present in the Southern  Lazio area (Central Italy). The 
University of Cassino has about fourteen thousand students prevalently from Southern 
Lazio and in small part from the neighbouring regions (especially Campania). The 
student population consists of 57 % females  and 43%  males aged 18-44 years. 
Sampling and the questionnaire 
All students attending the Faculties of Literature and Philosophy, Economics, Law, 
Engineering, Sport Science  and the degree course of Nursing Sciences  were invited to 
participate in the survey. The only criterion of inclusion was being university students. 
Students attending the first year were informed directly in the classroom while others 
were informed through an invitation form sent by the secretary’s office. Informed 
consent for taking blood specimens and the use of personal data was obtained from all 
students  who participated in the survey, with data being collected using a specific form.   
Blood samples were collected in a medical university laboratory, after which students 
filled in  the questionnaire which  was specifically designed for the study and contained  
three different areas of inquiry. The first section of the questionnaire concerned socio-
demographic data as age, gender, marital status, family structure and parental 
educational level and occupation. The second section regarded information about 
previous history of MMR diseases and previous  history of MMR immunization. The 
third section evaluated the students’ knowledge about the following topics: definition of 
MMR, transmission pathway of the infection, risk during pregnancy, risk in adulthood, 
MMR vaccine and  precautions after vaccination. 
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Self reported history of MMR vaccination or the Official certification of vaccination 
issued by paediatricians or Local Health Agency  was requested to all the participants. 
Certification of the vaccination status was not a prerequisite for the study participation. 
Serological assay 
The concentration of human IgG antibodies for mumps, measles and rubella  was 
determined using a commercial  ELISA immunoenzymatic test (Radim) according to 
the manufacturer's instructions. 
Enzyme immunoassay method was used for the qualitative determination of anti IgG 
antibodies for measles and mumps. The calculation of results obtained by qualitative 
assay, considered the optical density of each negative, positive and cut-off control.  
For qualitative IgG detection, the cut off recommended by the producer was used 
(OD>0.110): samples with optical density lower than the cut-off control were 
considered non reactive (negatives), samples with optical density higher than the cut-off 
control were considered reactive (positives), whilst samples with absorbance values 
ranging within 10% of the cut-off control were considered questionable and repeated 
for confirmation. The diagnostic specificity of the method was evaluated on a 
representative group of individuals with no immunity against Measles or Mumps IgG 
infection and results were respectively  94.1% for Measles and 100% for Mumps. The 
clinical sensitivity of the method was evaluated on a representative group of individuals 
having undergone Measles or Mumps IgG infection  and the results were respectively  
91.2% for Measles and 95.5% for Mumps.   
Enzyme immunoassay method was used for quantitative detection of IgG antibodies for 
rubella virus. Samples with IgG values lower than 15 IU/mL were considered non 
reactive for antirubella IgG antibodies (negative), samples with IgG values higher than 
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30 IU/mL were considered reactive for antirubella IgG antibodies (positive) and 
samples with IgG values between 15 and 30 IU/mL were considered questionable and 
repeated for confirmation in accordance with the producer’s instructions indicated in the 
Rubella IgG RADIM kit.  In this quantitative assay,  the calibrators were calibrated 
against the 2nd IS WHO 67/182, 1986. The 2nd British Standard for Anti-Rubella 
Serum, Human (67/182) was established by the National Biological Standards Board 
(NBSB) in 1986. The diagnostic specificity of the method was evaluated on a group of 
more than 100 samples with no immunity against Rubella infection andthe result was 
97.2%.  The diagnostic sensitivity of the method was evaluated on a group of more than 
200 samples having undergone past Rubella infection and the result was 100%.    
Statistical analysis  
Differences in qualitative variables among goups were assessed using the χ2 test and a 
P-value <0.05 was considered statistically significant. The logistic regression was used 
to identify significant predictors of seropositivity. Results of the logistic analysis were 
expressed as Odds Ratio (OR) and 95% Confidence Intervals (95% CI). Finally, three 
different multivariate models, one for each outcome variable (seropositivity), were built 
using the stepwise approach (backward elimination procedure). 
Statistical analysis was carried out using the program SPSS 12.0. 
 
 
Results  
Study population 
961 Students participated in the survey  (7.4% of  Cassino University population), with 
a median age of 22.0 years (range 18-44), 86.8% female, 13.2% male,  living mainly in  
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 8 
the nearby area  (province of  Frosinone 78.2% ). The distribution according to Faculty 
was as follows: Literature and Philosophy (28.5%), Nursing Sciences (12,1%), Sport 
Science (8.7%),  Law (6.9%), Engineering (6.0%),  Economics (4.7%); non responders 
were 33.2%. 
Seroprevalence 
As described in Table 1, the highest prevalence of specific IgG antibodies was detected 
for measles (93.2%), followed by mumps (91.4%) and rubella (81.3%). Lower 
seropositivity levels  for measles and mumps were found in the  31 years age group 
and in the 21-25 years age group. Seroprevalence for IgG antibodies against rubella was 
always lower than 85% up to the age of 30 years, resulting particularly low  in students 
under 20 (76.7%) whilst the highest prevalence (93.6%) was seen in the  31 years 
group. Questionable results were observed for mumps (1.1%) and for rubella (1.1%), 
without age or gender differences  
Only 0.3% of students had no IgG antibodies for all the three viruses under study and 
70.4% were positive for all three diseases. No statistically significant differences in the 
seroprevalence of positive antibodies were identified for gender for all three diseases.  
Personal history of previous MMR infections and MMR vaccination 
Most students interviewed declared they had had measles (63.1%), mumps (28.5%) and 
rubella (28.6%). Thisfact was supported by serological assays:  96.9% for measles, 
97.8% for mumps and 88.3% for rubella. Table 2 shows the history of the diseases 
crossed with the laboratory results and is statistically significant for all three.  
The reporting of unknown was 17.9% for measles, 33.7% for mumps and 30.5% for 
rubella. Having little or no memory of having contracted  mumps or  rubella could be 
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 9 
due to the fact that both these infections are characterized by a high percentage of 
asymptomatic cases.  
The majority of students who were asked to indicate whether they had had the 
combined vaccination or any of the three single vaccine in the past, said that they were 
not vaccinated or that they didn’t remember it. Only 111 students said to be vaccinated 
against measles, 46 against mumps and 103 against rubella. Primarily females (94), 
aged 21-25 years (42) and   under 20 years (28),  resulted vaccinated against rubella. In 
any case, we  did not identify statistically significant differences among males and 
females. Vaccination history was confirmed by serological tests  in 97.3% of cases  for 
measles, 93.5% for mumps and 90.3 % for rubella. When vaccination memory and 
serology tests were crossed, statistically significant results were seen only for measles. 
Only a negligible percentage of subjects (<1%) documented previous immunizations 
with the certificate issued from the Local Health Unit or the paediatrician.  
The low percentage of self declared vaccinations  suggests  that the presence of 
antibodies is likely to be related to natural disease. Thus, we preferred postponing the 
analysis of other variables to further detailed study. 
General Knowledge 
As far as knowledge inferred from the questionnaire was concerned,  only 2.3% of the 
students for measles, for mumps 19.7%, and for rubella 6.9% were aware of the 
complications of MMR infection contracted in adulthood by Only 1% of the students  
interviewed knew that the rubella virus could cause spontaneous miscarriage. Only 
3.3% recognized a generic risk to the foetus  but to the more specific answer regarding 
the transmission of the virus in pregnancy, the risk was perceived by most students 
(78.0%). Only 7.8% of responders  knew that an infant with CRS? is highly contagious 
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for a long time and 54.1% thought that their knowledge about rubella was insufficient. 
This result confirmed the high percentage of students who did not know the Rubeo test 
(43%). Regarding mumps 26.2% of students recognized a risk to pregnancy. Although 
vaccination was recognized as the best prevention tool available against measles 
(61.2%),  mumps (56.8%) and rubella (59%), non responders to this question were quite 
high (39.8%).   
Age group and gender were the main independent variables associated significantly 
with personal knowledge concerning  MMR. The 21-25 years age group and gender  
(female) influenced responses given from the interviewed regarding basic knowledge of  
contagiousness of all three viruses, including transmission modality and prevention 
against MMR (p<0.05). Therefore only the 21-25 years age group influenced degree of 
awareness regarding existence MMR vaccination.  
Univariate logistic analysis 
The logistic regression model, exemplified in Table 3, demonstrated that measles and 
mumps, on the one side, and rubella on the other side, show different patterns of 
predictors. In fact, while for measles and mumps the only significant predictor of 
seropositivity was the region of residence (higher OR in Lazio region),  being over 25 
years of age and vaccination  were independent predictors of seropositivity for rubella 
(OR=1.72).   
Multivariable logistic analysis 
Table 3 shows the multivariable analysis,  thatrevealed that the following variables were 
predictors of seropositivity: for Measles age over 25 (OR = 2.04; 95% CI: 1.02 – 4.10), 
region of residence other than Lazio (OR = 0.51; 95%CI: 0.28 – 0.90) and vaccination 
against measles (OR = 2.96; 95%CI: 1.00 – 9.67); for Mumps region of residence other 
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than Lazio (OR = 0.51; 95%CI: 0.29 – 0.89); for Rubella age over 25 (OR = 1.74; 
95%CI: 1.14 – 2.65) and vaccination against rubella (OR = 2.39; 95%CI: 1.18 – 4.86). 
 
Discussion   
Several surveys investigated the MMR seroprevalence in different countries in similar 
settings and age specific profiles of MMR  have shown a wide variation (Trevisan et al. 
2005; WHO 2005; Dominguez et al. 2006). In these similar studies however, most 
students were vaccinated and MMR vaccination coverage was higher. 
The Italian student population enrolled that was susceptible to measles (6.8%) was close 
to the estimated European level that must not exceed in over nine years old in order to 
eliminate this disease (Presidency of the Council of Ministers 2003; WHO 2005; 
Ramsay 1999). Positive results according national strategies were reached for mumps 
too (Presidency of the Council of Ministers 2003). On the other hand, the level of 
susceptibility to rubella is very high, in all age groups tested, and was always over 5%  
and particularly high in subjects under 25 (from 18.7% to 22.6%).  
The measles seropositivity rates in young adults found in our survey are higher than 
those obtained in a similar study conducted in Italy (Trevisan et al. 2005), and lower 
than those obtained in others conducted in Spain (WHO 2005; Dominguez et al. 2006). 
The mumps seropositivity rates  are higher than that obtained  in Italy (Trevisan et al. 
2005), and similar to others obtained in Spain 
 
(WHO 2005; Dominguez et al. 2006). On 
the other hand Rubella seropositivity is always lower compared to the other European 
studies (WHO 2005; Dominguez et al. 2006). The percentage of those reporting to have 
had measles and were immune is very similar to the percentage  reported in a study 
carried out in Italian children born before 1990 (Grandolfo et al. 1998) but, as 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 12 
multivariate logistic regression suggests and other surveys confirm (Baer et al 2005; 
Murray and Linch 1998), historical information on measles, mumps and rubella 
infection cannot be a reliable predictor.  
The high measles seroprevalence in these mostly unvaccinated students can hardly be a 
surprise. Our results are supported by a study conducted on pupils born  in the late 
1980s when 50% of children from 36 months in Southern Italy to 5-6 years in Northern 
Italy (Grandolfo et al. 1998) achieved natural infection.  
Although the susceptibility to measles is not very low in the population  studied,  
suboptimal MMR vaccination coverage in our province (Langiano et al. 2005) increases 
the risk that one may contract measles. Other serological studies are needed that involve  
younger cohorts because of the low vaccination coverage in the past. A probable 
unvaccinated status, and fewer opportunities to acquire natural infection increase the 
spread of the virus. 
Our results underline the importance of catch-up activities among adolescents and 
young adults to reduce the rate of susceptibility in this age-group and to reduce the 
regional differences in vaccination coverage (Bonanni et al. 2007; Ciofi degli Atti et al. 
2006;  Presidency of the Council of Ministers 2003). 
The susceptibility seen in our young adult students could expose them to a risk of 
contracting measles and rubella with more serious implications (Bonanni et al. 2007; 
Hamilton-West 2006). Therefore, there is a strong need to raise their level of 
consciousness and to motivate them to request vaccination. 
In the last outbreaks reported in European countries, including Italian adolescents, 
young adults were particularly affected by measles, because  most of the poplation were 
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unvaccinated or incompletely vaccinated ( Filia et al. 2008; Andrews et al. 2008; 
Nardone et al. 2003).  
Outbreaks of measles, mumps and rubella in older susceptible cohorts have occurred in 
Europe  in the recent years and they are still occurring (Hamilton-West 2006; Andrews 
et al. 2008; Sartorius et al. 2005; Schmidt et al. 2006) The cases of Mumps notified in 
Italy in 2006 by the Ministery of Health confirm the susceptibility in young adults 
(www.ministerosalute.it).  
The herd immunity for mumps is estimated at about 75-86% (Donaghy et al. 2006), and 
the  theoretical level of antibodies required to interrupt the transmission of mumps is 
estimated between 85% and 90% (Nardone et al.2003). Although   asymptomatic 
mumps infections may be more common  especially in adults (Sartorius et al. 2005), the 
last epidemic peak in  the province of Frosinone reported 137  cases with median age of 
7 vs. 285 with median age of 10 reported  in 1995 (Langiano et al. 2007). In this setting, 
mumps seroprevalence was always greater than 90% in all age groups considered and   it 
seems that a guaranteed level of acquired immunity through natural infection has been 
reached although these data need to be integrated with other serological studies 
assessing immunitary status in other younger age groups and completed with MMR 
vaccination coverage of 95% with the first dose in all Italian regions.  
The susceptibility rates for rubella obtained  in our results  are far from the value 
obtained in national surveys in similar age groups (8%) and even farther from the target 
of 5% set by the National Plan for Measles  and Congenital Rubella Elimination 
launched in 2003 (Giambi et al.2008; Presidency of the Council of Ministers 2003).  
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Suboptimal seroprevalence rates without gender difference, especially for rubella, 
highlight the failure of previous  selective rubella vaccination policy targeted at pre-
adolescent girls that had been  recommended in Italy since 1972 (Osborne et al. 2000).  
 As a consequence of the suboptimal vaccination coverage, a high proportion of subjects 
remain susceptible to rubella virus and a recent survey suggested that the late increase 
of MMR vaccination coverage in childhood has not had an impact on seroprevalence in 
childbearing age women.In fact, it is believed that over 5% of them are still susceptible 
to rubella infection (Rota et al. 2007). Vaccination is one of the most effective measures 
in the prevention of congenital rubella syndrome (CRS) ( WHO 2005) but despite its 
documented benefits our sample show that there are still childbearing women who are 
not being adequately immunized. In fact, only a small proportion of females reported 
having received rubella vaccination, mainly those aged under 24. From a public health 
perspective,  this leads to a very inadequate coverage (highest proportion susceptible for 
rubella). The susceptibility value among our students neither prevents the circulation of 
the virus nor the risk of  CRS (WHO 2003; Presidency of the Council of Ministers 
2003; WHO 2005).  
Nowadays,  interventions targeting childbearing age women are not yet satisfactory and, 
although rubella vaccine is free of charge and preconceptional screening is available, 
these opportunities are substantially missed reflecting that this offer is prevalently based 
on providing immunization through vaccination services though the active support of 
public health services and widespread awareness campaigns targeted towards this group 
are lacking. 
Surveillance data in fact,  , show that less than 25% of women with suspected rubella 
during pregnancy had undergone rubeo-test before pregnancy, even if it is offered free 
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charge by the Italian National Health Service  before and during pregnancy (Giambi et 
al.2008). 
The present study has some interesting strengths and limitations. Concerning the 
strengths, the results from the regression analysis revealed that factors such as 
geographical residence (for MMR), age and vaccination (for measles and mumps) are 
significantly associated to seroprevalence of these three infections. Moreover, our study 
demonstrated that students have  low levels of knowledge concerning measles, mumps 
and rubella and were not practicing preventive behaviours that reduce their level of risk 
(e.g. MMR vaccination). These findings have important implications for school health 
and suggest that education programmes should be considered and implemented. 
However, the results of this study need to be interpreted with caution, since several 
limitations are recognised. First of all, it only involved students participating on 
voluntary basis, therefore results might not be generalized  to other student populations. 
Replication studies need to be conducted at universities of different sizes and in 
different geographical areas. A possible selection bias could have occurred concerning 
gender, since the prevalence of participants were women. Likewise, higher responses 
were obtained in the Faculties where female students were the majority.  However, we 
have to consider that the over represented number of females in our sample could bias 
the results. Given that infections occur with equal frequency in men and women, as well 
as the immunological response, and that gender appeared to have an influence only for 
measles, it remains unclear whether females have a better serological response to the 
measles vaccine than men (Dominguez et al 2006; Gdalevich et al. 2002). As such, the 
selection bias in this study is likely to be limited. Moreover our situation presents a low 
percentage of subjects vaccinated for measles. On the other hand, the preponderance of 
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women allowed us to better investigate rubella susceptibility,  which is of great 
importance for the women considering the teratogenic effects which may occur from 
infection during pregnancy. 
Concerning the study design, we must consider that  vaccination status is self-reported, 
and a possible recall bias could have occurred since almost all students involved did not 
supply vaccination certificate and thus results could have been distorted. However, this 
possibility may not influence the study in a systematic way since the clinical signs of 
these infectious diseases are the most useful indicator of the presence of the diseases 
themselves. The likelihood of recognising the diseases, even by non health personnel, 
and subsequent related recall is very high. 
This study shows that sampled young adults can be exposed to an increasing risk of 
MMR infection related to the history of vaccination campaigns and outbreaks in the 
area where they lived their childhood. Concerted efforts are necessary to educate young 
adults about the benefits of MMR vaccination particularly for rubella.  Co-operation is 
required not only between national and regional levels but especially at a  Local Health 
Unit level and should be enhanced in order to increase immunity rates for rubella in 
childbearing women. 
 
Conclusions 
Public Health Local authorities should  promote, in their action plan against MMR,  
much more incisive educational programmes in order to encourage young adults to have 
MMR vaccinations and achieve a MMR vaccination recovery.This method is the only 
way to increase the seroprevalence rate needed to interrupt transmission of MMR and 
could be easily and quickly reached.  Special attention should be paid to  the recovery of 
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rubella susceptible females  in these age cohorts in order to reduce the risk of CRS in 
non- immune pregnant women. In this context, an added value could be represented by 
the process of formal Health Technology Assessment of these vaccinations, with the 
aim of considering not only the epidemiological, clinical and economic impact of the 
vaccinations, but also the legal, social and bioethical aspects related to the vaccinations 
themselves (La Torre et al. 2007).  Finally, the need to establish collaborations is urgent 
in order to train  and create of an operational network among professional staff in the 
health care area (e.g. general practitioners, gynaecologists and obstetricians) that could 
help women to increase their knowledge of their immune status and encourage the use 
of rubeo-test and rubella vaccination. 
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Reviewer #1: Manuscript Number: JOPH-D-09-00054 
 
Dear Author, 
 
the submitted article ("Are measles,mumps and rubella a Public Health issue in 
young adults? Results from a seroprevalence survey in university students in 
Italy") needs some major changes before it can be resubmitted.  
 
Proof-reading of the article by a native English speaker is strongly 
recommended. It'll enhance the understanding of several parts made by the 
authors. 
 
Materials Methods 
 
The study design is not precisely described, for example: 
-    The description of the study population is not precise: Exclusion / 
Inclusion criteria are missing. Is it a representative sample? Are the students 
included in the survey from one or different study programmes? 
Answer: We did not used criterions of exclusion, since the matter object of the 
search, the criterion of inclusion was being university students, the population 
target of our study.  
 
- The questionnaire should be described in more detail  
Answer: following the suggestion of the reviewer we added more details. 
(The first section of the questionnaire concerned socio-demographic data 
as age, gender, marital status, family structure and parental educational 
level and occupation. The second section regarded information about 
previous history of MMR diseases and previous  history of MMR 
immunization. The third section evaluated the students’ knowledge about 
the following topics: definition of MMR, transmission pathway of the 
infection, risk during pregnancy, risk in adulthood, MMR vaccine and  
precautions after vaccination). 
 
-    The information on the vaccination status through self-reporting is rather 
invalid. It is not described by the authors if the official certification of the 
vaccination status was a prerequisite for the study participation.  
 
Answer: We added  “Certification of the vaccination status was not a 
prerequisite for the study participation”  at the end of the paragraph Sampling 
and the questionnaire. 
 
-    It is unclear whether all students of the university were asked to 
participate. For this study design it is a prerequisite to sign an informed 
consent. It remains unclear in the manuscript.  
Answer: thanks to the reviewer suggestions, we added more details.  
(All students attending the university were invited to participate in the 
survey. Informed consent for taking blood specimens and the use of 
personal data was obtained from all students  who participated in the 
survey, with data being collected using a specific form.)   
 
-    A description of the serological test used for this survey should include 
more information (e.g. validated test system or not, manufacturer, detailed cut-
off values etc.) 
Authors' Response to Reviewers' Comments
Answer: It was using a commercial  ELISA immunoenzymatic test (Radim) according 
to the manufacturer's instructions. we added more details in the paragraph  
serological assay. 
(The concentration of human IgG antibodies for mumps, measles and rubella  
was determined using a commercial  ELISA immunoenzymatic test (Radim) 
according to the manufacturer's instructions.Enzyme immunoassay method 
was used for the qualitative determination of anti IgG antibodies for 
measles and mumps. The calculation of results obtained by qualitative 
assay, considered the optical density of each negative, positive and cut-
off control. For qualitative IgG detection, the cut off recommended by 
the producer was used (OD>0.110): samples with optical density lower than 
the cut-off control were considered non reactive (negatives), samples 
with optical density higher than the cut-off control were considered 
reactive (positives), whilst samples with absorbance values ranging 
within 10% of the cut-off control were considered questionable and 
repeated for confirmation.) 
 
 
Results 
 
The results should be described more precisely. 
-    The authors should describe why the study population consists mainly out of 
women (86,8%)?  
Answer: we introduced in the discussion section a clearer statement about that 
 
 
-    The tables are not self-explanatory, description of p-values is not clear 
enough.  
Answer: we introduced in the tables p values in a more detailed way. Moreover, 
in table 3 p values were not reported, since we wanted to avoid replications, 
after presenting the 95%CI of the OR. 
 
 
-    The description of seroprevalence data is of limited value without 
information on the official and certified vaccination status of the subjects. It 
remains unclear how many positive tests are a result of vaccination or natural 
infection. 
 
Answer: The main aim of our study was to assess the level of 
susceptibility for Measles, Mumps and Rubella  in a sample of university 
students. As described in “results” only 111 students said to be vaccinated 
against measles, 46 against mumps and 103 against rubella, and since only a 
negligible percentage of them (<1%) documented previous immunizations with 
the certificate issued from the Local Health Unit or the paediatrician, we 
preferred postponing the analysis of other variables to further detailed 
study. However, vaccination history resulted confirmed by serologic test  in 
97.3% of cases  for measles, 93.5% for mumps and 90.3 % for rubella and 
disease history among positive and negative test MMR was reported in tab.2   
 
 
Discussion 
 
-    Should be more structured and also shortened 
Answer: the discussion was hopefully better structured and also shortened 
according to the comments of the reviewer. 
 
 
-    Methodological limits of the study design, like recall- and selection bias, 
should be described in more detail. Are there any strengths of the study?  
Answer: strengths and limitations of the study are presented in more detailed 
way 
 
 
-    The consequences of the study concluded by the authors are not 
comprehensible, as it is not obvious whether the seroprevalence rate needed to 
interrupt transmission of MMR is due to wild type infections or MMR vaccination.  
 
Answer: a statement on this suggestion made by the reviewer was added in the 
Conclusion paragraph. 
 
Reviewer #2: The aim of the study was to assess seroprevalence against measles, 
mumps and rubella among Italian students and to find out whether seropositivity 
had been obtained from natural  infection or vaccination and to assess the 
students' knowledge on these the infections in and outside pregnancy.  
The survey yields a number of interesting findings: 
1.    Almost all students had antibodies against mumps and measles whereas some 
20 % of the students were still susceptible for rubella. 
2.    Most of the students have converted to seropositive from infection rather 
from vaccination.  
3.    The students' knowledge about the risks of measles, mumps and rubella with 
respect to pregnancy and else wise was appallingly poor. 
 
I have some suggestions to approve the paper: 
 
1.    Please describe the recruitment procedure in more detail: The 
participation rate of 7.4 % was extremely low. Were really all students invited 
to participate in this investigation or only those in the first year? Potential 
sources of ´bias need to be discussed!  
Answer: All students attending the Faculties of Literature and Philosophy, 
Economics, Law, Engineering, Sport Science  and the degree course of Nursing 
Sciences  were invited to participate in the survey. Students attending the 
first year were informed directly in the classroom while others were informed 
through an invitation form sent by the secretary’s office. Informed consent for 
taking blood specimens and the use of personal data was obtained from all 
students  who participated in the survey, with data being collected using a 
specific form.  A more detailed discussion on possible source of bias has been 
added.  
 
2.    The table two is very difficult to understand. "Do not" probably means do 
not know; please correct the rows for diseases history among positive or 
negative test for MMR for measles, mumps and rubella. These do not evidently add 
up of to 100 % but should for each headline "disease history among positive for 
MMR" as well as among "disease history" among negative for MMR.  
Answer: we corrected table 2 according to reviewer’s suggestions 
 
3.    I did not find table three with the modelling very helpful. I would rather 
suggest to leave out this table and to present the information on the students' 
knowledge about measles, mumps and rubella complications in table three instead.  
Answer: we did not remove table 3, since we are convinced that the results 
demonstrated the influence of possible determinants of seropositivity for MMR, 
taking into account the control of potential confounding factors. Moreover, as 
suggested by the reviewer, we add information concerning students' knowledge 
about MMR. 
 
 
Table 1- Positive seroprevalence IgG antibodies of Measles, Mumps and Rubella  (MMR) stratified by 
gender, age group and residence 
 
 
Personal date 
 
Number tested Measles 
 
p- value Mumps 
 
p- value Rubella p- value 
 
 
n 
 
% 
 
n 
 
% 
 
n %  
Age group            
18-20 271 254 93.7 0.02 251 92.6 0.7 208 76.7 0.04 
21-25 432 395 91.4  389 90.0  351 81.2  
26-30 208 202 97.1  193 92.7  176 84.6  
31 47 42 89.4  43 91.4  44 93.6  
total 958 893 93.2  876 91.4  779 81.3  
           
Sex           
Male  127 117 92.1 0.90 111 87.4 0.1 107 84.2 0.30 
Female 834 778 93.2  768 92.0  675 81.0  
total 961 895 93.1  879 91.4  782 81.3  
           
Residence           
Frosinone 752 707 94.0 0.06 695 92.4 0.04 609 80.1 0.20 
Caserta 107 95 88.8  91 85  81 75.7  
Latina 45 42 93.3  43 95.5  43 95.5  
total 904 844 93.4  829 91.7  733 81.0  
 
 
 
Table
 
Table 2- Disease  history among the positive and  negative test MMR  
 
 
  
Measles 
 
Mumps 
 
Rubella 
 
Diseases History 
 
N (% ) 
 
N (% ) 
 
N (% ) 
Yes 607 (63.2) 273 (28.5) 275 (28.6) 
No 152 (15.8) 259 (27) 232 (24.1) 
Do not know 202 (21.0) 426 (44.5) 454 (47.3) 
    
 
Diseases History among 
positive test MMR 
 
N (%) 
 
N (% ) 
 
N (% ) 
Yes  586  (65.4)  267 (30.3)  242 (31)  
No 121 (13.5)  221 (25.1)  176 (22.6)  
Do not know 189 (21.1)  392 (44.6)  362 (46.4)  
    
 
Diseases History among 
negative test MMR 
 
N (%) 
 
N (% ) 
 
N (% ) 
Yes 19 (30.2)  6 (8.8)  30 (18.1)  
No 30 (47.6)  36 (52.9)  51 (30.7) 
Do not know 14 (22.2)  26 (38.3)  85 (51.2) 
p- value < 0.001 < 0.001 0.01 
 
 
 
 
 
 
 
 
 
 
Table  3- Predictors and associated odds ratio of MMR seroprevalence rate. 
 
 
 
Measles 
 
Mumps 
 
Rubella 
Characteristics 
Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
       
       
Gender       
Male (reference) 1.0  1.0  1.0  
Female 1.11 (0.53-2.31)  1.80 (0.97-3.35)  0.83 (0.49-1.40)  
       
Age group        
< 26 (reference) 1.0 1.0 1.0  1.0 1.0 
≥ 26 1.95 (0.98-3.90) 2.04 (1.02-4.10) 1.19 (0.67-2.12)  1.72 (1.13-2.62) 1.74 (1.14-2.65) 
       
Marital status       
Not married (reference) 1.0  1.0  1.0  
Married 3.57 (0.86-14.83)  0.71 (0.34-1.48)  1.53 (0.82-2.88)  
       
Having given birth       
Yes na  0.73 (0.28-1.91)  1.75 (0.73-4.15)  
No (reference)   1.0  1.0  
       
Vaccination       
Yes 
 
2.74 (0.84-8.89) 
2.96 (1.00- 9.67) 
 
1.10 (0.33-3.64)  2.34 (1.16-4.74) 2.39(1.18 – 4.86) 
 
No (reference) 1.0 1.0 1.0  1.0 1.0 
       
Region       
Lazio 1.0 1.0 1.0 1.0 1.0  
Other region 0.49 (0.28-0.87) 0.51 (0.28-0.90) 0.51 (0.29-0.88) 0.51 (0.29-0.89) 0.84 (0.53-1.23)  
       
na= not applicable 
 
 
